Dr. Zinner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1025 Walnut St.
700
Philadelphia, PA 19107Phone+1 215-503-5098Fax+1 215-503-3408- Is this information wrong?
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1996 - 1999
- University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1996 - 1998
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1993 - 1996
- Georgetown University School of MedicineClass of 1993, MD
- University of California, BerkeleyBA, Japanese Language, 1986
Certifications & Licensure
- KY State Medical License 2019 - 2025
- NJ State Medical License 2017 - 2021
- PA State Medical License 1994 - 2021
- TX State Medical License 1999 - 2020
- DE State Medical License 2017 - 2019
Awards, Honors, & Recognition
- Fellows Competition for Clinical Trainees Award 1998
- Merit Award American Society of Clinical Oncology, 1997
- National Research Service Award NIH Training for Academic Oncology/Hematology, 1997
Clinical Trials
- Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer Start of enrollment: 2003 Jun 01
- Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2006 May 01
- Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer Start of enrollment: 2005 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPhase I study of sapanisertib with carboplatin and paclitaxel in mTOR pathway altered solid malignancies.Omar Alhalabi, Roman Groisberg, Ralph Zinner, Andrew W Hahn, Aung Naing, Shizhen Zhang, Apostolia M Tsimberidou, Jordi Rodon, Siqing Fu, Timothy A Yap, David S Hong, M...> ;NPJ Precision Oncology. 2023 Apr 18
- 17 citationsTadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma.Adam J Luginbuhl, Jennifer M Johnson, Larry A Harshyne, Alban J Linnenbach, Sanket K Shukla, Angela Alnemri, Gaurav Kumar, David M Cognetti, Joseph M Curry, Nikita Kot...> ;Clinical Cancer Research. 2022 Mar 1
- 3 citationsEngaging Patients with Late-Stage Non-Small Cell Lung Cancer in Shared Decision Making about TreatmentRonald E. Myers, Shailesh M. Advani, Pamela Myers, Preethi Selvan, Gregory D. Garber, Brooke Worster, Neal Flomenberg, Andrew E. Chapman, Ralph Zinner> ;Journal of Personalized Medicine. 2021 Oct 1
- Join now to see all
Journal Articles
- STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid f...Subbiah V, McMahon C, Patel S, Zinner R, Silva EG, Elvin JA, Subbiah IM, Ohaji C, Ganeshan DM, Anand D, Levenback CF, Berry J, Brennan T, Chmielecki J, Chalmers ZR, Ma..., J Hematol Oncol, 1/1/2015
- A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701)Bepler G, Zinner RG, Moon J, Calhoun R, Kernstine K, Williams CC, Mack PC, Oliveira V, Zheng Z, Stella PJ, Redman MW, Gandara DR, Cancer, 1/1/2014
- Mutation profiling in Cholangiocarcinoma: Prognostic and Therapeutic implicationsChuri CR, Shroff R, Wang Y, Rashid A, Kang HC, Weatherly J, Zuo M, Zinner R, Hong D, Meric-Bernstam F, Janku F, Crane CH, Mishra L, Vauthey JN, Wolff RA, Mills G, Javle M, PLoS One, 1/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Overcoming BRAF/MEK resistance using vemurafenib with crizotinib or sorafenib in patients with BRAF-mutant advanced cancers: phase I studyKato S, Naing A, Falchook G, Holley VR, Velez-Bravo VM, Patel S, <b>Zinner RG</b>, Piha-Paul SA, Tsimberidou AM, Hong DS, Kurzrock R, Meric-Bernstam F, Janku, Proceedings of the 106th Annual Meeting of the American Association for Cancer Research (AACR), 1/1/2015
- Phase I study of BPM 31510 (ubidecarenone) in patients with advanced solid tumorsShah MA, Yu p, Narain N, Sarangarajan R, Kiebish M, Vishnudas V, Sun Y, Rodrigues L, Akmaev VR, Brouwer S, Stevens J, Benaim E, Zinner R, Proc Am Assoc of Ca Res (AACR), 1/1/2015
- Rapid, automated BRAF mutation testing of cell-free DNA from plasma of patients with advanced cancers using the novel Idylla platformJanku F, Huang1 HJ, Claes B, Falchook GS, Fu S, Tsimberidou AM, Hong DS, Naing A, Wheler JJ, Piha-Paul SA, Karp DD, Subbiah V, Zinner RG, Ramzanali N, Luthra R, Patel ..., Proceedings of the 106th Annual Meeting of the American Association for Cancer Research (AACR), 1/1/2015
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
- Member
- Member
- Member
Hospital Affiliations
- University of Kentucky Albert B. Chandler HospitalLexington, Kentucky
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: